David M Hyman

16PUBLICATIONS
97CO-AUTHORS
Molecular targetsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivities.

Tripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick

|Mar 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.

Ezra Y Rosen, Helen H Won, Youyun Zheng

|Feb 24, 2021
OncoTree: A Cancer Classification System for Precision Oncology.

Ritika Kundra, Hongxin Zhang, Robert Sheridan

|Dec 28, 2019
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.

Maria M Rubinstein, David M Hyman, Imogen Caird

|Nov 27, 2019
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.

Pedram Razavi, Bob T Li, David N Brown

|Nov 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic

Pageof 3

Frequent Collaborators

7 joint publications

David Solit

5 joint publications

Alexander Drilon

4 joint publications

Ahmet Zehir

4 joint publications

Michael F Berger